CME Group Inc. (NASDAQ:CME) Shares Acquired by NewEdge Advisors LLC

NewEdge Advisors LLC grew its stake in CME Group Inc. (NASDAQ:CME) by 3.8% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 46,937 shares of the financial services provider’s stock after purchasing an additional 1,733 shares during the quarter. NewEdge Advisors LLC’s holdings in CME Group were worth $9,228,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Salomon & Ludwin LLC acquired a new position in CME Group during the first quarter worth about $28,000. Y.D. More Investments Ltd acquired a new position in CME Group during the second quarter worth about $36,000. McClarren Financial Advisors Inc. boosted its position in CME Group by 66.1% during the second quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock worth $39,000 after acquiring an additional 78 shares during the last quarter. Asset Dedication LLC boosted its position in CME Group by 515.2% during the second quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock worth $40,000 after acquiring an additional 170 shares during the last quarter. Finally, Rise Advisors LLC acquired a new position in CME Group during the first quarter worth about $41,000. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insiders Place Their Bets

In other news, CFO Lynne Fitzpatrick sold 754 shares of the company’s stock in a transaction on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the transaction, the chief financial officer now owns 13,261 shares in the company, valued at approximately $2,877,504.39. The sale was disclosed in a document filed with the SEC, which is available at this link. In other news, CFO Lynne Fitzpatrick sold 754 shares of the company’s stock in a transaction on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the transaction, the chief financial officer now owns 13,261 shares in the company, valued at approximately $2,877,504.39. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the transaction, the director now owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. The disclosure for this sale can be found here. 0.30% of the stock is currently owned by company insiders.

CME Group Price Performance

Shares of CME opened at $220.65 on Tuesday. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $223.80. The firm’s 50 day moving average price is $210.11 and its 200 day moving average price is $207.42. The company has a market cap of $79.45 billion, a P/E ratio of 25.10, a PEG ratio of 8.74 and a beta of 0.55. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.10.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, July 24th. The financial services provider reported $2.56 EPS for the quarter, topping the consensus estimate of $2.53 by $0.03. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The company had revenue of $1.53 billion during the quarter, compared to analysts’ expectations of $1.53 billion. During the same quarter in the previous year, the business posted $2.30 EPS. The firm’s revenue was up 12.7% on a year-over-year basis. On average, research analysts forecast that CME Group Inc. will post 9.94 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th were issued a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a yield of 2.08%. The ex-dividend date was Monday, September 9th. CME Group’s dividend payout ratio (DPR) is presently 52.33%.

Wall Street Analyst Weigh In

A number of equities analysts have commented on the stock. Royal Bank of Canada assumed coverage on shares of CME Group in a research note on Friday. They set a “sector perform” rating and a $235.00 target price on the stock. Barclays lifted their target price on shares of CME Group from $208.00 to $209.00 and gave the stock an “equal weight” rating in a research note on Thursday, July 25th. JPMorgan Chase & Co. lifted their target price on shares of CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a research note on Thursday, July 25th. Piper Sandler reaffirmed an “overweight” rating and set a $225.00 target price on shares of CME Group in a research note on Tuesday, August 20th. Finally, TD Cowen assumed coverage on shares of CME Group in a research note on Thursday, September 26th. They set a “hold” rating and a $221.00 target price on the stock. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, CME Group currently has a consensus rating of “Hold” and an average price target of $212.54.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.